Related Experiment Video
Updated: Jan 4, 2026
05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
7.2K
A Gut Check Explains Improved Glucose Metabolism after Surgery
Blandine Laferrère1, François Pattou2
1New York Obesity Research Center, Division of Endocrinology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Cell Metabolism
|November 7, 2019
Summary
Biliopancreatic diversion surgery achieves higher diabetes remission rates than Roux-en-Y gastric bypass. A study matched weight loss and found the gut plays a key role in BPD
Area of Science:
- Metabolic surgery
- Gastroenterology
- Endocrinology
Background:
- Bariatric surgery, including Biliopancreatic diversion (BPD) and Roux-en-Y gastric bypass (RYGB), is effective for weight loss and managing type 2 diabetes.
- Previous studies suggest BPD may lead to superior diabetes remission rates compared to RYGB.
- Differences in surgical mechanisms and their impact on metabolic outcomes require further investigation.
Purpose of the Study:
- To compare the efficacy of Biliopancreatic diversion (BPD) and Roux-en-Y gastric bypass (RYGB) in achieving diabetes remission.
- To identify the key differences in surgical effects between BPD and RYGB, particularly concerning weight loss.
- To investigate the role of the gastrointestinal tract in mediating the metabolic benefits of these procedures.
Main Methods:
- Comparative study design matching patients based on percentage of weight loss.
- Analysis of clinical outcomes, focusing on diabetes remission rates.
- Investigation of gastrointestinal physiological changes post-surgery.
Main Results:
- Biliopancreatic diversion (BPD) demonstrated a higher frequency of diabetes remission compared to Roux-en-Y gastric bypass (RYGB).
- Careful matching for percentage weight loss highlighted significant differences in the effects of the two surgical procedures.
- The gastrointestinal tract was identified as a major site contributing to the differential effects observed between BPD and RYGB.
Conclusions:
- Biliopancreatic diversion (BPD) is associated with more frequent diabetes remission than Roux-en-Y gastric bypass (RYGB), even after accounting for equivalent weight loss.
- The gut's role is crucial in differentiating the metabolic outcomes of BPD and RYGB.
- Further research into the specific gut mechanisms is warranted to optimize surgical strategies for type 2 diabetes management.
Related Concept Videos
01:15Hypoglycemia and Glucagon
752
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
752
01:16Hormones Regulating Blood Glucose
6.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.2K
01:24Glucagon-like Receptor Agonists
792
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
792
01:02Glucose Homeostasis: Regulation of Blood Glucose
3.7K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.7K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.0K
01:26Glucose Absorption Into the Small Intestine
34.5K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
34.5K